Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587821 · ClinicalTrials.gov registry record
Peptide Profiles of Women Undergoing Breast Biopsy
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 571
- Enrollment target
NCT00587821: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00587821 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 571 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587821 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 571 participants
- Enrollment target
Study Summary
This study is being done to learn about blood proteins. We want to see if the blood proteins in women whose biopsies show breast cancer are different from the blood proteins in women whose biopsies do not show breast cancer. The goal of this study is to develop a blood test than can help detect breast cancers when they are very small and easy to cure.
Interventions
- OTHER Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 571 participants |
| Start Date | 2006-01 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587821
The ClinicalTrials.gov registry entry for NCT00587821 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 571 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT00587821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587821 about?
NCT00587821 is a clinical study titled "Peptide Profiles of Women Undergoing Breast Biopsy". This study is being done to learn about blood proteins. We want to see if the blood proteins in women whose biopsies show breast cancer are different from the blood proteins in women whose biopsies do not show breast cancer. The goal of this study is to develop a blood test than can help detect brea...
What is the current status of trial NCT00587821?
This trial is currently completed. The enrollment target is 571 participants. The study started on 2006-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00587821?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT00587821?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.